Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Obesity 2Endometrial Hyperplasia 2Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Metformin 1Metabolic Diseases 1Ketosis 1Insulin Resistance 1Infertility 1Glioma 1Glioblastoma 1Endometrial Neoplasms 1Diabetes, Gestational 1Communicable Diseases 1Brain Neoplasms 1Astrocytoma 1

Interventions

camrelizumab 2Injections 2toripalimab 1epigallocatechin gallate 1atezolizumab 1Zinc 1Tablets 1Quercetin 1Nivolumab 1Metformin 1Imatinib Mesylate 1Gemcitabine 1Everolimus 1Epirubicin 1Docetaxel 1Cisplatin 1Carboplatin 1Capecitabine 1CP protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Triple Negative Breast Neoplasms × Metformin × Clear all
NCT05680662 2023-01-11

The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism

Ministry of Health, Saudi Arabia

Phase EARLY_PHASE1 Unknown
200 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡